Blood Grouping Reagents Market: Market Insights and Future Trends 2024-2032
The Blood Grouping Reagents Market Size was valued at USD 1.76 Billion in 2023 and is projected to reach USD 2.95 Billion by 2031, growing at a CAGR of 6.6% over the forecast period. The blood grouping reagents market size is witnessing steady growth due to rising demand for reliable blood typing tools in clinical diagnostics, blood banks, and transfusion services across the globe.
Blood grouping reagents are essential components in determining blood types, ensuring safe transfusions, and minimizing the risk of hemolytic reactions. The market is being propelled by the increasing number of surgeries, accidents, and chronic conditions requiring frequent blood transfusions. Advances in reagent technologies and automation in diagnostic labs are also playing a significant role in boosting market demand.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/2525
Key Players & Their Blood Grouping Reagent Products
- Merck KGaA – Anti-Human Globulin, Blood Typing Reagents
- Bio-Rad Laboratories, Inc. – IH-1000, IH-500, IH-Com, IH-Card, IH-Complete, IH-Reader
- Beckman Coulter, Inc. – PK7400 Automated Microplate System, Microplates for Blood Grouping
- Haemokinesis Pty Ltd – QWALYS 3 EVO, QWALYS 4, Erytra Blood Grouping Analyzer
- MTC Med. Produkte GmbH – MTC ABO and RhD Typing Reagents
- DAY Medical SA – MD-DayGel, DayPlate, DayEry, DayReagent
- Rapid Labs Ltd – Rapid Labs ABO & RhD Blood Grouping Reagents
- Ortho Clinical Diagnostics – ORTHO VISION, ORTHO BioVue System, ORTHO Workstation
- Diagast SAS – E.M. Technology, QWALYS 3, Erytra
- Atlas Medical – Atlas Blood Grouping Reagents, Atlas Gel Cards
- Alba Bioscience Limited – ALBAclone, ALBAcheck, ALBAsera
- PerkinElmer – LABChip GX, DELFIA Blood Grouping Kits
- Lorne Laboratories Limited – Lorne Blood Grouping Reagents, Lorne ABO & RhD Typing Kits
- BAG Diagnostics – BAGene ABO Genotyping Kit, BAGene RhD Genotyping Kit
- Biorex Diagnostics – Biorex ABO & RhD Typing Reagents
- Cardinal Health – Cardinal Health Blood Bank Reagents
- Thermo Fisher Scientific Inc. – ProVue, ScanGel, Oxoid Blood Typing Reagents
- Yuvraj Biobiz Incubator India Pvt – YBIO Blood Typing Reagents
- Tulip Diagnostics – Tulip ABO & Rh Blood Grouping Reagents
- Aikang – Aikang Blood Typing Reagents, Aikang Gel Card System
Key Highlights:
- Market size expected to grow from USD 1.76 Bn in 2023 to USD 2.95 Bn by 2031
- CAGR projected at 6.6% from 2024 to 2031
- Rising prevalence of chronic diseases and emergency cases driving blood typing needs
- Growth in blood donation drives and global awareness about safe transfusion practices
- Technological advancements in diagnostics and reagent formulation
- Increased adoption of automated systems in blood testing laboratories
- North America and Asia-Pacific identified as high-growth regional markets
Future Scope:
The future of the blood grouping reagents market looks promising as healthcare systems across the world continue to prioritize safety and precision in transfusion practices. The expansion of healthcare infrastructure in emerging economies, coupled with growing investments in diagnostic technologies, will likely contribute to market expansion. Moreover, the development of fast, automated, and highly sensitive reagent-based testing kits offers significant potential for innovation and differentiation in the coming years.
Conclusion:
As the demand for safe and efficient blood typing continues to grow, the blood grouping reagents market is well-positioned to capitalize on emerging opportunities. With rising healthcare awareness, improving diagnostic capabilities, and technological advancements, stakeholders in the market can expect a period of sustained growth and innovation.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Other Related Reports:
Comments
0 comment